2016
DOI: 10.1124/mol.116.104372
|View full text |Cite
|
Sign up to set email alerts
|

Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors

Abstract: The metabotropic glutamate 5 receptor and the cannabinoid type 1 receptor are G protein-coupled receptors that are widely expressed in the central nervous system. Metabotropic glutamate 5 receptors, present at the postsynaptic site, are coupled to Gα proteins and display an excitatory response upon activation, whereas the cannabinoid type 1 receptor, mainly present at presynaptic terminals, is coupled to the G protein and triggers an inhibitory response. Recent studies suggest that the glutamatergic and endoca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(25 citation statements)
references
References 160 publications
1
24
0
Order By: Relevance
“…The mGlu 5 /CB 1 signalosome complex might play a major role in nociception. 40 The literature has very little to say about the link between the ECs and glutamatergic pathways in the periphery and the importance of the relationship between circulating levels of mediators of the EC systems and glutamate. To the best of our knowledge, this is the first study to report about the relationship of circulating anandamide and glutamate levels in chronic pain patients and HC before and after a physical exercise intervention.…”
Section: Discussionmentioning
confidence: 99%
“…The mGlu 5 /CB 1 signalosome complex might play a major role in nociception. 40 The literature has very little to say about the link between the ECs and glutamatergic pathways in the periphery and the importance of the relationship between circulating levels of mediators of the EC systems and glutamate. To the best of our knowledge, this is the first study to report about the relationship of circulating anandamide and glutamate levels in chronic pain patients and HC before and after a physical exercise intervention.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, this increased mGluR5 availability positively correlated with avoidance symptom severity in the PTSD group 20 . Another PET study revealed increased endocannabinoid receptor type 1 (CB1) availability associated with PTSD 22 , which is interesting because CB1 receptors are inhibitory presynaptic receptors that are functionally linked to post-synaptic mGluR5 signaling 23 .…”
Section: The American Psychiatricmentioning
confidence: 99%
“…Indeed, in excitatory synapses, mGlu 5 Rs, that are typically located peri-synaptically, are activated by glutamate (Glut) "spill over" occurring during hyper-excitable states (like epileptic seizures), so producing a feed-forward mechanism. 16 After Glut binding, mGlu 5 Rs (coupled with G q/11 proteins) activate phospholipase C β (PLCβ), which catalyzes the synthesis of diacylglycerol (DAG), a second messenger and precursor of 2-AG. When high levels of DAG are available, the enzyme diacylglycerol lipase α (DGLα) converts DAG into 2-AG, which migrates in a retrograde way to the presynaptic membrane.…”
Section: Phytocannabinoids and Endocannabinoids: A Brief Overviewmentioning
confidence: 99%
“…When high levels of DAG are available, the enzyme diacylglycerol lipase α (DGLα) converts DAG into 2-AG, which migrates in a retrograde way to the presynaptic membrane. 16,17 Interestingly, mGlu 5 Rs, PLCβ and DGLα are all anchored together and structurally organized by HOMER, a scaffold protein, forming a supramolecular complex called "2-AG signalome". 16 When 2-AG binds pre-synaptic CB 1 (coupled with G i/o ), its activation triggers various molecular pathways, including the inhibition of adenylate cyclase and of voltage-gated calcium channels (VGCC), which determines the decrease of Ca 2+ intracellular levels at the presynaptic terminal, resulting in neurotransmitter (Glut) release reduction.…”
Section: Phytocannabinoids and Endocannabinoids: A Brief Overviewmentioning
confidence: 99%